Kuros Biosciences AG ( CSBTF) - Key Metrics
CSBTF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $1.69 | $0.09 | $0.05 | $0.02 |
| 2025Q2 | $1.59 | -$0.05 | -$0.07 | -$0.09 |
| 2024Q4 | $1.17 | -$0.11 | $0.09 | $0.08 |
| 2024Q2 | $0.86 | -$0.01 | -$0.01 | -$0.03 |
| 2023Q4 | $0.57 | -$0.24 | -$0.06 | -$0.06 |
CSBTF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 73.70 |
| 2025Q2 | ? | -134.56 |
| 2024Q4 | ? | -48.68 |
| 2024Q2 | ? | -537.17 |
| 2023Q4 | ? | -3.68 |
CSBTF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.08% | ? |
| 2025Q2 | -0.35% | ? |
| 2024Q4 | 0.37% | ? |
| 2024Q2 | -0.21% | ? |
| 2023Q4 | -1.83% | ? |
CSBTF
Price: $26
52 week price:
Earnings Per Share: -0.16 USD
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 975.4 million